Funding Opportunities

NIH Funding Opportunities

Notice to Extend the Expiration Date for PAR-11-205 "Alcohol Education Project Grants (R25)"
Notice NOT-AA-14-005 from the NIH Guide for Grants and Contracts
Mon, 14 Apr 2014 07:58:06 EST

Request for Proposals (RFP) Announcement: "Development of Medical Countermeasures to Mitigate and/or Treat Radiation-Induced Lung Injury after a Radiological/Nuclear Incident BAA-NIAID-DAIT-NIHAI2014001
Notice NOT-AI-14-050 from the NIH Guide for Grants and Contracts
Wed, 16 Apr 2014 02:20:06 EST

Public Pre-application Webinar for PAR-14-067 "Fundamental Mechanisms of Affective Science and Decisional Processes in Cancer Control (U01)"
Notice NOT-CA-14-042 from the NIH Guide for Grants and Contracts
Wed, 16 Apr 2014 03:51:59 EST

Request for Information: Current Clinical Questions in Post Resuscitation Hypothermia
Notice NOT-GM-14-112 from the NIH Guide for Grants and Contracts
Fri, 18 Apr 2014 06:51:55 EST

Request for Information (RFI): Impact of DSM-5 Changes to Diagnostic Criteria for Autism Spectrum Disorders (ASD) on Research and Services
Notice NOT-HD-14-012 from the NIH Guide for Grants and Contracts
Mon, 14 Apr 2014 08:00:59 EST

NINDS Anticipates Holding Future Meetings among PDs/PIs of NINDS-Funded Institutional Training (T32) Programs
Notice NOT-NS-14-026 from the NIH Guide for Grants and Contracts
Fri, 18 Apr 2014 06:50:32 EST

NIH and AHRQ Announce Updated Policy for Application Submission
Notice NOT-OD-14-074 from the NIH Guide for Grants and Contracts
Thu, 17 Apr 2014 10:23:57 EST

NIH Will Open the Research Performance Progress Report (RPPR) for All Type 5 Non-SNAP Progress Reports on April 25, 2014
Notice NOT-OD-14-079 from the NIH Guide for Grants and Contracts
Tue, 15 Apr 2014 01:39:40 EST

Notice of NIH HeLa Genome Sequence Data Submission and Access Policy
Notice NOT-OD-14-080 from the NIH Guide for Grants and Contracts
Wed, 16 Apr 2014 02:51:56 EST

Notice of NIH Improving the Financial Conflict of Interest (FCOI) Module for Submission of Financial Conflict of Interest Reports to the NIH Beginning on April 25, 2014
Notice NOT-OD-14-081 from the NIH Guide for Grants and Contracts
Fri, 18 Apr 2014 12:26:11 EST

Special Topic Research Education Course: Exploring Auditory and Vestibular biology (R25)
Funding Opportunity RFA-DC-15-001 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.The goal of this NIDCD R25 program is to support educational activities that foster a better understanding of biomedical, behavioral and clinical research and its implications. To this end, this funding opportunity announcement encourages the development of creative educational activities with a primary focus on Courses for Skills Development. Applications are encouraged from research intensive institutions to develop a research skill development course that will expose participants to research tools and methodologies focused on auditory and vestibular research approaches.
Tue, 15 Apr 2014 12:35:18 EST

Evaluation of Iron Species in Healthy Subjects Treated with Generic and Reference Sodium Ferric Gluconate (U01)
Funding Opportunity RFA-FD-14-019 from the NIH Guide for Grants and Contracts. The objective of this study is to conduct in vivo studies to compare plasma total iron (TI), transferrin bound iron (TBI), non-transferrin bound iron (NTBI) levels and oxidative stress after i.v. administration of RLD and generic sodium ferric gluconate injections in healthy subjects. This study is part of post-market surveillance on approved generic products, which can help address potential concerns regarding the quality of generic iron complex products and support the Agencys review standards.
Wed, 16 Apr 2014 02:01:23 EST

Prospective Studies on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft survivals (U01)
Funding Opportunity RFA-FD-14-020 from the NIH Guide for Grants and Contracts. The objective of this study is to conduct prospective clinical studies to investigate the impact of generic immunosuppressants on short term acute rejection and long term patient graft survival. The outcome of this study will help respond to public concerns regarding the interchangeability of generic immunosuppressants and improve review practices of generic immunosuppressants if necessary. The results obtained from this study can be compared to those of retrospective analysis, providing comprehensive perspectives and better research options regarding generic immunosuppressant interchangeability.
Wed, 16 Apr 2014 12:34:11 EST

Retrospective Analysis on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft Survivals (U01)
Funding Opportunity RFA-FD-14-021 from the NIH Guide for Grants and Contracts. The objective of this study is to conduct a retrospective analysis of the impact of generic immunosuppressants on short term acute rejection and long term patient and graft survival since the introduction of generic immunosuppressants. The outcome of this study will help respond to public concerns regarding the interchangeability of generic immunosuppressants and improve review practices of generic immunosuppressants if necessary.
Wed, 16 Apr 2014 11:56:06 EST

The Effect of Different Preparation Methods on the In Vitro and In Vivo Performance of Solid Dispersion Formulations (U01)
Funding Opportunity RFA-FD-14-023 from the NIH Guide for Grants and Contracts. The objective of this study is to investigate the in vitro and in vivo performance for solid dispersion drug products made from different manufacturing processes or polymer carriers, as well as their performance consistency during storage and among batches.The investigation should identify critical process parameters and critical quality attributes for solid dispersion made from different preparation methods and develop discriminating analytical methods.
Wed, 16 Apr 2014 12:10:37 EST

Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01)
Funding Opportunity RFA-FD-14-024 from the NIH Guide for Grants and Contracts. The purpose of this project is to conduct a prospective PK/PD study to identify the key product attributes and patient factors that may impact the PK/PD and therapeutic equivalence of metoprolol products. The findings from the PK/PD study will help establish scientific and regulatory standards for assuring therapeutic equivalence of generic metoprolol products.
Wed, 16 Apr 2014 02:10:07 EST

Developing Improved Assessments of Tissue Oxygenation (R43/R44)
Funding Opportunity RFA-HL-15-003 from the NIH Guide for Grants and Contracts. This FOA encourages applications to support the development and/or improvement of devices that can evaluate the dynamic changes in microvascular blood flow and tissue oxygenation in clinical research applications.Devices designed to measure temporal changes in regional perfusion and oxygen delivery following red blood cell transfusion or in peripheral vascular disease are of particular interest.
Tue, 15 Apr 2014 08:57:36 EST

Developing Improved Assessments of Tissue Oxygenation (R41)
Funding Opportunity RFA-HL-15-007 from the NIH Guide for Grants and Contracts. This FOA encourages applications to support the development and/or improvement of devices that can evaluate the dynamic changes in microvascular blood flow and tissue oxygenation in clinical research applications.Devices designed to measure temporal changes in regional perfusion and oxygen delivery following red blood cell transfusion or in peripheral vascular disease are of particular interest.
Tue, 15 Apr 2014 08:59:32 EST

Developing Improved Assessments of Tissue Oxygenation (R44)
Funding Opportunity RFA-HL-15-019 from the NIH Guide for Grants and Contracts. This FOA encourages applications to support the development and/or improvement of devices that can evaluate the dynamic changes in microvascular blood flow and tissue oxygenation in clinical research applications.Devices designed to measure temporal changes in regional perfusion and oxygen delivery following red blood cell transfusion or in peripheral vascular disease are of particular interest.
Tue, 15 Apr 2014 07:57:18 EST

Limited Competition: Transdisciplinary Collaborative Centers for Health Disparities Research Coordinating Center (U54)
Funding Opportunity RFA-MD-14-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to establish a Coordination Center to facilitate and support consortium-wide activities for NIMHD Transdisciplinary Collaborative Centers (TCCs) for Health Disparities Research. The TCC Coordination Center will serve as the focal point for disseminating TCC consortium information to the broader research community and public, including research results, scientific data, and methods to assess the impact of consortium activities on health disparities locally, regionally and nationally.
Wed, 16 Apr 2014 09:36:32 EST

Limited Competition: NIMHD Exploratory Centers of Excellence Pilot Research Projects (P20)
Funding Opportunity RFA-MD-14-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for innovative pilot projects that complement or enhance research and dissemination activities supported by NIMHD Exploratory Centers of Excellence (COE). Applications must propose at least two but not more than four pilot projects that utilize or leverage Exploratory COE core resources. Projects that align with ongoing COE specific aims and establish new collaborations to stimulate trans-disciplinary and/or translational research in priority areas, including HIV/AIDS, are particularly encouraged.
Wed, 16 Apr 2014 10:42:07 EST

Undiagnosed Diseases Gene Function Research (R21)
Funding Opportunity RFA-RM-14-005 from the NIH Guide for Grants and Contracts. This Exploratory/Developmental Research Funding Opportunity intends to support gene function studies in collaboration with the Undiagnosed Diseases Network (UDN) building upon the NIH Intramural Research Programs Undiagnosed Diseases Program (NIH-UDP). Responsive applications will propose to investigate the underlying genetics, biochemistry and/or pathophysiology of newly diagnosed diseases in association with the respective gene variant(s) identified through the UDN. In recent years, gene function studies combined with genetic and genomic analyses and metabolic studies have greatly improved diagnoses of these very rare diseases and advanced scientific knowledge of the underlying pathogenesis. This initiative is funded through the NIH Common Fund, which supports cross-cutting programs that are expected to have exceptionally high impact.
Fri, 18 Apr 2014 09:31:50 EST

Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21)
Funding Opportunity PA-14-176 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to encourage applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 21). Applications to promote positive health behavior(s) should target social and cultural factors, including, but not limited to: schools, families, communities, population, food industry, age-appropriate learning tools and games, social media, social networking, technology and mass media. Topics to be addressed in this announcement include: effective, sustainable processes for influencing young people to make healthy behavior choices; identification of the appropriate stage of influence for learning sustainable lifelong health behaviors; the role of technology and new media in promoting healthy behavior; identification of factors that support healthy behavior development in vulnerable populations, identification of barriers to healthy behaviors; and, identification of mechanisms and mediators that are common to the development of a range of habitual health behaviors. Given the many factors involved in developing sustainable health behaviors, applications from multidisciplinary teams are strongly encouraged. The ultimate goal of this FOA is to promote research that identifies and enhances processes that promote sustainable positive behavior or changes social and cultural norms that influence health and future health behaviors.
Wed, 16 Apr 2014 08:03:58 EST

Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R01)
Funding Opportunity PA-14-177 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to encourage applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 21). Applications to promote positive health behavior(s) should target social and cultural factors, including, but not limited to: schools, families, communities, population, food industry, age-appropriate learning tools and games, social media, social networking, technology and mass media. Topics to be addressed in this announcement include: effective, sustainable processes for influencing young people to make healthy behavior choices; identification of the appropriate stage of influence for learning sustainable lifelong health behaviors; the role of technology and new media in promoting healthy behavior; identification of factors that support healthy behavior development in vulnerable populations, identification of barriers to healthy behaviors; and, identification of mechanisms and mediators that are common to the development of a range of habitual health behaviors. Given the many factors involved in developing sustainable health behaviors, applications from multidisciplinary teams are strongly encouraged. The ultimate goal of this FOA is to promote research that identifies and enhances processes that promote sustainable positive behavior or changes social and cultural norms that influence health and future health behaviors.
Wed, 16 Apr 2014 08:04:05 EST

Clinical Trial Planning Grant for Interventions and Services to Improve Treatment and Prevention of HIV/AIDS (R34)
Funding Opportunity PA-14-179 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA invites applications that propose completion of planning, design, and collection of preliminary data in order to 1) support efforts to prevent acquisition and transmission of HIV infection, or to 2) improve treatment and care for persons who are HIV infected, or both 1) and 2).Awards are limited to 3 years and may include 1) the development and/or pilot testing of interventions, 2) the adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale effectiveness trials, or 3) innovative services research that require preliminary testing.
Thu, 17 Apr 2014 11:06:59 EST

mHealth Tools for Underserved Populations with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R01)
Funding Opportunity PA-14-180 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patientprovider communication, adherence to treatment and self-management of chronic diseases in underserved populations. With the rapid expansion of cellular networks and substantial advancements in Smartphone technologies, it is now possible - and affordable - to transmit patient data digitally from remote areas to specialists in urban areas, receive real-time feedback, and capture that consultation in a database. These mHealth tools, therefore, may facilitate more timely and effective patient-provider communication through education communication around goal setting, treatment reminders, feedback on patient progress and may improve health outcomes. This announcement encourages the development, testing and comparative effective analysis of interventions utilizing mHealth technologies. There is also an interest in studying mHealth technologies in underserved populations.
Fri, 18 Apr 2014 09:50:08 EST

mHealth Tools for Underserved Populations with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R21)
Funding Opportunity PA-14-181 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patientprovider communication, adherence to treatment and self-management of chronic diseases in underserved populations. With the rapid expansion of cellular networks and substantial advancements in Smartphone technologies, it is now possible - and affordable - to transmit patient data digitally from remote areas to specialists in urban areas, receive real-time feedback, and capture that consultation in a database. These mHealth tools, therefore, may facilitate more timely and effective patient-provider communication through education communication around goal setting, treatment reminders, feedback on patient progress and may improve health outcomes. This announcement encourages the development, testing and comparative effective analysis of interventions utilizing mHealth technologies. There is also an interest in studying mHealth technologies in underserved populations.
Fri, 18 Apr 2014 09:50:30 EST

Exploratory Clinical Trials of Mind and Body Interventions for NCCAM High Priority Research Topics (R34)
Funding Opportunity PAR-14-182 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity is to support early phase clinical trials of mind and body approaches for conditions that have been identified by NCCAM as high priority research topics. This funding opportunity is intended to support exploratory clinical trials, which will provide data that are critical for the planning and design of a subsequent controlled cohort study, clinical efficacy or effectiveness study, or a pragmatic trial. The data collected should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial. This FOA is not appropriate for support of randomized clinical trials to test or determine efficacy or effectiveness. Applications that propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial are not appropriate for this announcement. The subsequent larger trial should have the potential to make a significant impact on public health.
Fri, 18 Apr 2014 10:04:01 EST